Immunotherapy of type 1 diabetes mellitus: current state-of-the-art and prospects. Part 2
https://doi.org/10.14341/probl200955531-38
Abstract
This review summarizes experimental findings obtained in immunological studies of diabetes mellitus. Principal immunotherapeutic approaches to the treatment of diabetes are described. Putative mechanisms behind the development of immunotolerance are considered. A brief summary of previously reported and on-going clinical studies is presented.
References
1. Верещагин Е. И., Хощенко О. М., Душкин М. И. // Цитокины и воспаление. - 2008. - Т. 7, № 2. - С. 3-8.
2. Allen H. F., Klingensmith G. J., Jensen P. et al. // Diabetes Care. - 1999. - Vol. 22. - P. 1703-1707.
3. Anonymous. The Canadian-European Randomized Control Trial Group // Diabetes. - 1988. - Vol. 37. - P. 1574- 1582.
4. Belghith M. et al. // Nat. Med. - 2003. - Vol. 9. - P. 1202- 1208.
5. Bielekova B. et al. // Nat. Med. - 2000. - Vol. 6, N 10. - P. 1167-1175.
6. Bingley P. J., Christie M. R., Bonifacio E. et al. // Diabetes. - 1994. - Vol. 43. - P. 1304-1310.
7. Bjork E., Kampe O., Andersson A., Karlsson F. A. // Diabetologia. - 1992. - Vol. 35. - P. 490-493.
8. Bjork E., Berne C., Kampe O. et al. // Diabetes. - 1996. - Vol. 45. - P. 1427-1430.
9. Bresson D., Togher L., Rodrigo E. et al. // J. Clin. Invest. - 2006. - Vol. 116. - P. 1371-1381.
10. Brod S. A., Atkinson M., Lavis V. R. et al. // J. Interferon Cytokine Res. - 2001. - Vol. 21. - P. 1021-1030.
11. Chase H. P., Butler-Simon N., Garg S. K. et al. // Pediatrics. - 1990. - Vol. 85. - P. 241-245.
12. Cook J. J., Hudson I., Harrison L. C. et al. // Diabetes. - 1989. - Vol. 38. - P. 779-783.
13. Coutant R., Landais P., Rosilio M. et al. // Diabetologia. - 1998. - Vol. 41. - P. 1040-1046.
14. Eisenbarth G. S., Srikanta S., Jackson R. et al. // Diabetes Res. - 1985. - Vol. 2. - P. 271-276.
15. Eizirik D. L., Strandell E., Sandler S. // Diabetologia. - 1988. - Vol. 31. - P. 168-174.
16. Elliott J. F., Marlin K. L., Couch R. M. // Diabetes Care. - 1998. - Vol. 21. - P. 1691-1693.
17. Feutren G., Papoz L., Assan R. et al. // Lancet. - 1986. - Vol. 2. - P. 119-124.
18. Gonzalo J. A., Gonzalez-Garcia A., Kalland T. et al. // Eur. J. Immunol. - 1993. - Vol. 23. - P. 2372-2374.
19. Gross D. J., Sidi H., Weiss L. et al. // Diabetologia. - 1994. - Vol. 37. - P. 1195-1201.
20. Hagopian W. A., Karlsen A. E., Petersen J. S. et al. // Endocrinology. - 1993. - Vol. 132. - P. 2674-2681.
21. Herold K. C., Hagopian W., Auger J. A. et al. // N. Engl. J. Med. - 2002. - Vol. 346. - P. 1692-1698.
22. Kalland T., Alm G., Stalhandske T. // J. Immunol. - 1985. - Vol. 134. - P. 3956-3961.
23. Karussis D. M., Meiner Z., Lehmann D. et al. // Neurology. - 1996. - Vol. 47. - P. 341-346.
24. Keymeulen B., Vandemeulebroucke E., Ziegler A. G. et al. // N. Engl. J. Med. - 2005. - Vol. 352. - P. 2598-2608.
25. Kullin M., Li Z., Hansen J. B. et al. // Diabetes. - 2000. - Vol. 49. - P. 1131-1136.
26. Larson E. T. // Int. J. Immunopharmacol. - 1987. - Vol. 9. - P. 425.
27. Nagler-Anderson C., Bhan A. K., Podolsky D. K., Terhorst C. // Nat. Immunol. - 2004. - Vol. 5. - P. 119-122.
28. Nouri-Shirazi M., Thomson A. W. // Expert Opin. Biol. Ther. - 2006. - Vol. 6, N 4. - P. 325-339.
29. O'Brien D., Butler N., Chase H. P. et al. // Diabetes Care. - 1988. - Vol. 11. - P. 297.
30. Oikawa Y. et al. // J. Immunol. - 2003. - Vol. 171, N 11. - P. 5865-5875.
31. Ortqvist E., Bjork E., Wallensteen M. et al. // Diabetes Care. - 2004. - Vol. 27. - P. 2191-2197.
32. Pozzilli P., Visalli N., Boccuni M. L. et al. // Diabet. Med. - 1994. - Vol. 11. - P. 98-104.
33. Rabinovitch A., Suarez-Pinzon W. L., Shapiro A. M. et al. // Diabetes. - 2002. - Vol. 51. - P. 638-645.
34. Rapoport M. J., Weiss L., Mor A. et al. // J. Immunol. - 1996. - Vol. 157. - P. 4721-4725.
35. Redondo C., Flores I., Gonzales A. et al. // J. Clin. Invest. - 1998. - Vol. 98, N 5. - P. 1245-1252.
36. Rothe H. et al. // J. Immunol. - 1999. - Vol. 163, N 3. - P. 1230-1236.
37. Silverstein J., Maclaren N., Riley W. et al. // N. Engl. J. Med. - 1988. - Vol. 319. - P. 599-604.
38. Skyler J. S., Rabinovitch A. // J. Diabet. Compl. - 1992. - Vol. 6. - P. 77-88.
39. Suarez-Pinzon W. L., Lakey J. R. T., Brand S. J., Rabinovitch A. // J. Clin. Endocrinol. Metab. - 2004. - Vol. 90, N 6. - P. 3401-3409.
40. Wenzlau J. M., Juhl K., Yu L. et al. // Proc. Natl. Acad. Sci. US. - 2007. - Vol. 104, N 43. - P. 17040-17045.
41. Zhang Z. L. et al. // Acta Pharmacol. Sin. - 2003. - Vol. 24, N 8. - P. 751-756.
Review
For citations:
Laptev D.N. Immunotherapy of type 1 diabetes mellitus: current state-of-the-art and prospects. Part 2. Problems of Endocrinology. 2009;55(5):31-38. (In Russ.) https://doi.org/10.14341/probl200955531-38
Views:
1864
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
